AKIKO vs NIVABUPA: Stock Comparison

AKIKO vs NIVA BUPA HEALTH INS CO LUpdated 21 Sept 26, 4:08 PM ISTNSE & company filings

NIVA BUPA HEALTH INS CO L is the larger company by market capitalisation. AKIKO shows a lower P/E, a higher ROE and a higher ROCE, while NIVA BUPA HEALTH INS CO L shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AKIKO leads 4; NIVABUPA leads 4 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AKIKONIVABUPA

Valuation lens

What price are you paying?

Market CapContext only
₹461 Cr
₹14,892 Cr
P/E RatioAKIKO has the lower reading
16.42x
111.55x
P/B RatioNIVABUPA has the lower reading
6.02x
3.84x
EPSAKIKO has the higher reading
₹16.17
₹0.71
Book ValueContext only
₹59.17
₹23.09
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NIVABUPA is the larger company
₹14,892 Cr vs ₹461 Cr
P/E Ratio
AKIKO has a lower P/E
16.42x vs 111.55x
P/B Ratio
NIVABUPA has a lower P/B
3.84x vs 6.02x
EPS
AKIKO has higher earnings per share
₹16.17 vs ₹0.71
Revenue Growth (TTM YoY)
NIVABUPA has faster revenue growth
26.8% vs 0%
EPS Growth (TTM YoY)
NIVABUPA has faster EPS growth
90.2% vs 0%
ROE
AKIKO has a higher ROE
21.09% vs 0%
ROCE
AKIKO has a higher ROCE
18.2% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAKIKONIVABUPA
SectorFinancial Services
IndustryGeneral Insurance

Price

MetricAKIKONIVABUPA
Live Price₹80.48
Day Change1.12%
Volume9.58 L
52-Week High₹91.4
52-Week Low₹67.5
Distance from 52W High-11.95%

Valuation

MetricAKIKONIVABUPA
Market Cap₹461 Cr₹14,892 Cr
P/E Ratio16.42x111.55x
P/B Ratio6.02x3.84x
EPS₹16.17₹0.71
Book Value₹59.17₹23.09
Dividend Yield0%0%

Growth

MetricAKIKONIVABUPA
Revenue Growth (TTM YoY)0%26.8%
EPS Growth (TTM YoY)0%90.2%
Qtr Sales Growth41.13%
Qtr Profit Growth54.29%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricAKIKONIVABUPA
ROE21.09%0%
ROCE18.2%0%
Net Margin0%4.34%
Operating Margin13.27%
Debt to Equity0.25x0.07x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricAKIKONIVABUPA
Promoter Holding67.29%0%
FII Holding0.04% 0.04 pp12.09% 1.49 pp
DII Holding1.86% 1.18 pp16.17% 0.32 pp
Public Holding30.82% 1.21 pp16.44% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AKIKO and NIVA BUPA HEALTH INS CO L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.